All hell broke loose in Europe last year after a French manufacturer was busted for substituting an industrial grade silicon in breast implants with a sub-standard gel used in mattresses. The European Parliament issued the PIP Resolution about a year ago demanding a credible response to the scandal in which up to 500,000 women in 65 countries may have received implants from Poly Implant Prothese (PIP; La Seyne-sur-Mer, France).

Eitan Machover is the newly appointed CEO of Wellsense, an Israeli-founded company whose U.S. operations are based in Nashville, Tennessee. Machover previously served as CEO of Ovalum Vascular. He was also a founder and managing director of MediTech Advisors, an advisory and venture capital group, and also spent nearly 15 years with General Electric in various corporate, capital and healthcare roles. He talked with MDD Senior Editor Jim Stommen about the company's work in developing the MAP System and the serious and costly problem of hospital-acquired pressure ulcers.